Xiao Juan Li
Director/Miembro de la Junta en CHINA NATIONAL MEDICINES CORPORATION LTD. .
Perfil
Xiao Juan Li is currently a Director at China National Medicines Co., Ltd.
Prior to this, she worked as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and as a Manager-Investment Planning & Audit Division at China National Pharmaceutical Industry Corp.
Ltd.
Cargos activos de Xiao Juan Li
Empresas | Cargo | Inicio |
---|---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Miembro de la Junta | 07/04/2022 |
Antiguos cargos conocidos de Xiao Juan Li.
Empresas | Cargo | Fin |
---|---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Corporate Officer/Principal | - |
JIANGSU HENGRUI MEDICINE CO., LTD. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Health Technology |
- Bolsa de valores
- Insiders
- Xiao Juan Li